Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Xiang, Zhang, Shijie, Wang, Dongguang, Zhang, Li, Huang, Jizheng, Zhang, Tianli, Fan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602210/
https://www.ncbi.nlm.nih.gov/pubmed/34803671
http://dx.doi.org/10.3389/fphar.2021.709819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602210/
https://www.ncbi.nlm.nih.gov/pubmed/34803671
http://dx.doi.org/10.3389/fphar.2021.709819

Ejemplares similares